PremiumCompany AnnouncementsCynata Therapeutics Joins National Regenerative Medicine Initiative Cynata Therapeutics Forms New Scientific Advisory Board to Enhance R&D Strategy Cynata’s Cymerus™ MSCs Show Promise in Heart Disease Treatment PremiumCompany AnnouncementsCynata Therapeutics Announces Expiry of CYPOA Options Cynata Therapeutics Director Updates Securities Holdings Cynata Therapeutics Issues New Securities to Boost Market Position PremiumCompany AnnouncementsCynata Therapeutics Announces Director’s Increase in Shareholding Cynata Therapeutics Issues Shares to Directors Post-Approval Cynata Therapeutics Expands Market Presence with New Securities Quotation